Skip to content

CFA Pharma

Active Private limited companyfounded 1986active for 40 yearsBlauwepoortstraat 1, 8902 YpresKBO/BCE: BE 0428.715.650

Annual accounts 2025

micro format, filed on 31-08-2026, 31 days late
€52,159
▼ 1.1%
€21,596
▼ 35.7%
€6,743
▼ 74.7%
€171,657
▼ 5.4%
29.3%
▼ 10.0 percentage points
2.64
▼ 0.69

Turnover is estimated at about €250,000, probably between €130,000 and €380,000. The abbreviated or micro format does not state turnover.

Balance sheet

balance sheet total €525,286 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

29.3%

Higher than 47% of the 25,428 companies filing micro accounts in retail trade (NACE 47) in 2025.

2.64

Higher than 73% of the 24,428 companies filing micro accounts in retail trade (NACE 47) in 2025.

1.3%

Higher than 41% of the 24,617 companies filing micro accounts in retail trade (NACE 47) in 2025.

CFA Pharma Middle half of the sector 80% of the sector Micro accounts in retail trade (NACE 47)

Net result: middle half · Equity: top quarter · Balance sheet total: top quarter · Working capital: top quarter

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024202320222021202020192018201720162015201420132012201120102009200820072006
49,26851,59219,08948,87250,17451,43850,19347,09926,59228,59027,38827,48423,232------20,289
34,41644,65618,64539,00937,74738,55136,53639,72524,56020,27320,53322,60620,879------22,135
146,1350000000268,3990011,4824,313-------
-1,575-115,82680,554-2,153-27,8487,60530,090-223,728-33,52517,487176,719-1,529-7,36813,87048,28330,532-4,315345-70,496-
171,657181,505164,09056,62754,90876,50377,04260,00339,593343,191322,918302,929292,328302,274278,298262,417240,323216,147193,488171,114
29.3%39.3%29.0%56.5%49.8%47.9%44.8%39.2%19.9%98.6%97.7%98.7%94.8%95.5%97.6%97.2%97.1%97.1%96.8%96.3%
2.643.332.033.353.053.353.733.851.1568.9242.1987.2220.1823.2944.3538.2936.4637.0133.0329.02
2.643.332.031.851.702.242.452.141.0161.7837.5976.9517.8120.6338.7333.1631.1331.0027.0623.11
2.411.542.450.771.011.091.231.554.040.010.020.010.060.050.020.030.030.030.030.04
4.4%17.4%0.5%19.5%19.0%16.7%14.6%7.4%3.3%4.9%5.2%6.2%6.8%7.8%5.7%8.4%10.1%10.5%11.6%12.9%
1.3%6.8%0.1%11.0%9.5%8.0%6.5%2.9%0.7%4.8%5.1%6.1%6.4%7.5%5.6%8.2%9.8%10.2%11.2%12.4%
4.787.4042.3788.8971.71---------------

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024202320222021202020192018201720162015201420132012201120102009200820072006
Balance sheet: assets
20/58 525,286389,747471,596247,026259,791300,259311,042303,072554,470353,700339,372318,216311,017315,834284,717269,454247,101222,149199,529177,220
21/28 248,751130,288148,288166,288178,098191,220205,800222,000252,9465,4558,61411,7743,450-------
22/27 248,751130,288148,288166,288178,098191,220205,800222,000252,9465,4558,61411,7743,450-------
22 136,463-------------------
23 --------2,2965,4558,61411,7743,450-------
26 112,288130,288148,288166,288178,098191,220205,800222,000250,650-----------
29/58 276,536259,459323,30880,73881,693109,039105,24281,072301,524348,244330,757306,442307,567315,834284,717269,454247,101222,149199,529177,220
3 --036,08636,08636,08636,08636,08636,08636,08636,08636,08636,08636,08636,08636,08636,08636,08636,08536,086
30/36 --036,08636,08636,08636,08636,08636,08636,08636,08636,08636,08636,08636,08636,08636,08636,08636,08536,086
40/41 270,431251,780199,8021,700--3,8089,7276,451--2,4042,0005008,9269,44517,6252,6366,2072,200
40 39,264171,88197,118-----------3,564495--3,207-
41 231,16779,899102,6841,700--3,8089,7276,451--2,4042,0005005,3628,95017,6252,6363,0002,200
50/53 ---------19,64619,646169,646169,646169,646144,646177,146177,146162,146137,14649,950
54/58 6,1057,679123,50642,95245,10572,95365,34935,259258,987292,512275,02698,30699,835107,20393,33345,05014,51818,83318,48888,984
490/1 ----502--------2,4001,7271,7271,7262,4481,603-
Balance sheet: equity and liabilities
10/49 525,286389,747471,596247,026259,791300,259311,042303,072554,470353,700339,372318,216311,017315,834284,717269,454247,101222,149199,529177,220
10/15 153,937153,194136,539139,545129,446143,771139,199118,863110,085348,647331,533314,159294,712301,546277,892261,996239,902215,750193,079170,734
10/11 28,00028,00028,00028,00028,00028,00028,00028,00028,000270,213270,213270,213270,2136,2006,2006,1986,1986,1986,1986,198
100 ------28,00028,00028,000295,000295,000295,000295,00030,98730,98730,98730,98730,98730,98730,987
101 ---------24,78724,78724,78724,78724,78724,78724,78924,78924,78924,78924,789
13 97,90797,16580,50984,160101,260115,585111,01590,67981,90178,25061,15037,50018,100293,100263,100243,100223,100198,100173,100153,100
130/1 2,8002,8002,8002,8002,8002,800--------------
130 ------2,8002,8002,80029,50029,50019,10018,1003,1003,1003,1003,1003,1003,1003,100
1311 2,8002,8002,8002,8002,8002,800--------------
133 95,10794,36577,70981,36098,460112,785108,21587,87979,10148,75031,65018,400-290,000260,000240,000220,000195,000170,000150,000
14 28,03028,03028,03027,3851861861841841841831696,4466,3992,2468,59212,69810,60411,45213,78111,436
17/49 371,349236,553335,057107,481130,346156,488171,842184,209444,3855,0537,8394,05716,30514,2886,8257,4587,1996,3996,4506,486
17 266,470158,599175,83983,371103,561123,952143,642163,140182,454-----------
170/4 256,470148,599175,83983,371103,561123,952143,642163,140182,454-----------
175 10,00010,000------------------
42/48 104,87977,954159,21824,11026,78532,53628,20021,069261,9315,0537,8393,51315,23913,5606,4207,0376,7786,0026,0416,106
42 38,75329,84629,21820,19020,10119,69019,49719,31517,546-----------
44 45,58738,10801,7421,7529,5311,4901,5112,1721,5632,9701,3042,253750750750750815808805
440/4 45,58738,10801,7421,7529,5311,4901,5112,1721,5632,9701,3042,253750750750750815808805
45 4,539-01,9384,9313,3157,213243-3,4904,0882,2093356816721,746650654406513
450/3 4,539-01,9384,9313,3157,213243-3,4904,0882,2093356816721,746650654406513
47/48 16,00010,000130,000240----242,213-781-12,65212,1294,9984,5415,3784,5334,8274,788
492/3 -----------5431,066728405421421397409380
Income statement
9900 52,15952,74221,37049,87151,13552,39451,11448,00927,04329,04027,83827,93223,77827,81527,04426,41926,28025,14224,39720,719
630 27,67318,00018,00011,81013,12214,58016,20030,94620,9093,1593,1593,159863------194
640/8 2,8901,1502,282999961956921910451451450449546443441503436435433430
9901 21,59633,5921,08937,06237,05236,85833,99316,1535,68325,43124,22924,32522,37027,37326,60425,91625,84424,70723,96420,095
75/76B 02460-0--012,6846495,2024,2824,2374,5935,0704,1704,3585,6477,5648,872
75 02460-0--012,6846495,2024,2824,2374,5935,0704,1704,3585,6477,5648,872
65/66B 10,3146,9744505507001,5261,7082,16712,88648155821,08875912,429460452452958411
65 10,3146,9744505507001,5261,7082,16712,88648155821,08875912,429460452452958411
9903 11,28226,86363836,51236,35235,33232,28413,9865,48126,03229,41628,02625,51831,20719,24429,62629,75029,90230,57028,556
67/77 4,539208-79,31311,72711,36111,9485,2081,8308,91812,0428,5795,5027,5533,3507,5325,5987,2318,2256,615
9904 6,74326,65664527,19924,62523,97120,3368,7783,65117,11417,37419,44720,01623,65415,89422,09424,15222,67122,34521,941
9905 6,74326,65664527,19924,62523,97120,3368,7783,65117,11417,37419,44720,01623,65415,89422,09424,15222,67122,34521,941
Appropriation of the result
9906 34,77354,68528,03027,38524,81124,15620,5208,9623,83517,28323,81925,84622,26232,24628,59232,69835,60436,45233,78136,436
14P 28,03028,03027,385186186---------------
791/2 -03,65117,10038,95019,400------268,500-------
691/2 74316,656--24,62523,97020,3368,7783,65117,10023,65019,40015,86330,00020,00020,00025,00025,00020,00025,000
691 ------------863-------
6920 ----------10,4001,00015,000-------
6921 74316,656--24,62523,97020,3368,7783,65117,10013,25018,400-30,00020,00020,00025,00025,00020,00025,000
694/7 6,00010,0003,65117,10038,95019,400------268,500-------
694 -03,65117,10038,95019,400------268,500-------
695 6,00010,000------------------
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The accounts for 20 older financial years, from 1986 to 2005, were filed as documents without figures as data, scans for example.

The full notes are in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 31-08-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank

The accounts were filed on 31-08-2026. The deadline was 31-07-2026, 7 months after the close on 31-12-2025 (article 3:10 of the Companies and Associations Code). Source: NBB, 2026-00470200.

Financial year Type Filed Reference Document
31-12-2025 micro format 31-08-2026 2026-00470200 PDF
31-12-2024 micro format 24-03-2026 2026-00060401 PDF
31-12-2023 micro format 31-08-2024 2024-00424143 PDF
31-12-2022 abbreviated format 18-07-2023 2023-00245256 PDF
31-12-2021 abbreviated format 04-07-2022 2022-20124210 PDF
31-12-2020 abbreviated format 07-07-2021 2021-32200083 PDF
31-12-2019 abbreviated format 01-07-2020 2020-24200279 PDF
31-12-2018 abbreviated format 04-07-2019 2019-28500525 PDF
31-12-2017 abbreviated format 12-07-2018 2018-33000263 PDF
31-12-2016 abbreviated format 26-06-2017 2017-21500449 PDF
31-12-2015 abbreviated format 24-06-2016 2016-22100308 PDF
31-12-2014 abbreviated format 22-06-2015 2015-19900231 PDF
31-12-2013 abbreviated format 23-06-2014 2014-19900226 PDF
31-12-2012 abbreviated format 27-06-2013 2013-23100043 PDF
31-12-2011 abbreviated format 25-06-2012 2012-21000431 PDF
31-12-2010 abbreviated format 04-07-2011 2011-25400348 PDF
31-12-2009 abbreviated format 14-06-2010 2010-17600076 PDF
31-12-2008 abbreviated format 22-06-2009 2009-26800203 PDF
31-12-2007 abbreviated format 14-07-2008 2008-39400345 PDF
31-12-2006 abbreviated format 14-06-2007 2007-21700306 PDF
31-12-2005 abbreviated format 19-06-2006 2006-25803508 PDF
31-12-2004 abbreviated format 04-07-2005 2005-39200631 PDF
31-12-2003 abbreviated format 13-07-2004 2004-45103546 PDF
31-12-2002 abbreviated format 09-07-2003 2003-42105181 PDF
31-12-2001 abbreviated format 30-07-2002 2002-44004828 PDF
31-12-2000 abbreviated format 28-09-2001 2001-60100680 PDF
31-12-1999 abbreviated format 30-06-2000 2000-34500303 PDF
31-12-1998 abbreviated format 30-06-1999 1999-27502861 PDF
31-12-1997 abbreviated format 26-06-1998 1998-23502763 PDF
31-12-1996 abbreviated format 30-06-1997 1997-24200761 PDF
31-12-1995 abbreviated format 28-06-1996 1996-27301847 PDF
31-12-1994 abbreviated format 27-12-1995 1995-61304930 PDF
31-12-1993 abbreviated format 12-07-1994 1994-29004685 PDF
31-12-1992 abbreviated format 08-10-1993 1993-39205175 PDF
31-12-1991 abbreviated format 13-07-1992 1992-21604089 PDF
31-12-1990 abbreviated format 08-10-1991 1991-27604218 PDF
31-12-1989 abbreviated format 16-11-1990 1990-27901524 PDF
31-12-1988 abbreviated format 12-12-1989 1989-26901573 PDF
31-12-1987 abbreviated format 06-02-1989 1989-00904654 PDF
31-12-1986 abbreviated format 22-02-1988 1988-01200311 PDF

Securities and guarantees

on own assets and for others
Item20252024202320222021
Debts secured on the company's own assets---€103,561€123,662
---€200,000€200,000
Carrying value of the mortgaged assets---€166,288€178,098

Source: notes to the 2021 to 2025 annual accounts (statement of debts and off-balance-sheet rights and commitments)

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets€146,135----
Financial fixed assets€0----
€27,673€18,000€18,000€11,810€13,122

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on CFA Pharma

The operating result for 2025 is 36% lower than in 2024.

Debt's share of the balance-sheet total rises from 60.7% to 70.7%. Equity and debt are higher.

Next steps